is a protein that in humans is encoded by the CLDN18 gene. It belongs to the group of claudins. CLDN18 belongs to the large claudin family of proteins...
5 KB (590 words) - 13:48, 29 September 2024
cancer. In Japan, zolbetuximab is approved for the treatment of people with CLDN18.2-positive, unresectable, advanced, or recurrent gastric cancer. In July...
10 KB (584 words) - 23:12, 30 September 2024
HGNC:2036 P56746 3135 CLDN16 HGNC:2037 Q9Y5I7 3136 CLDN17 HGNC:2038 P56750 3137 CLDN18 HGNC:2039 P56856 3138 CLDN19 HGNC:2040 Q8N6F1 3139 CLDN20 HGNC:2042 P56880...
277 KB (17 words) - 18:34, 6 October 2024
application (BLA) for Zolbetuximab, a monoclonal antibody targeting Claudin 18.2 (CLDN18.2), for the treatment of HER2-negative gastric or gastroesophageal junction...
27 KB (2,460 words) - 00:25, 13 September 2024
CLDN9, CLDN10, CLDN11, CLDN12, CLDN13, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN20, CLDN21, CLDN22, CLDN23 Occludin Hou J, Konrad M (2010-01-01)...
11 KB (1,301 words) - 05:45, 16 July 2024